HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jay S Skyler Selected Research

Jay S Skyler Research Topics

Disease

68Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2024 - 01/2004
10Insulin Resistance
01/2023 - 01/2009
9Hypoglycemia (Reactive Hypoglycemia)
02/2024 - 01/2004
8Type 2 Diabetes Mellitus (MODY)
01/2024 - 09/2002
5Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
12/2021 - 12/2018
5Autoimmune Diseases (Autoimmune Disease)
01/2019 - 07/2011
5Infections
01/2019 - 11/2009
3Chronic Renal Insufficiency
01/2024 - 01/2021
3Glucose Intolerance
01/2023 - 09/2009
2Body Weight (Weight, Body)
01/2024 - 06/2019
2Hyperglycemia
06/2019 - 03/2008
2Disease Progression
01/2019 - 06/2013
2Neutropenia
07/2011 - 11/2009
2Inflammation (Inflammations)
01/2009 - 01/2004
2Obesity
01/2009 - 09/2002
1Kidney Diseases (Kidney Disease)
01/2024
1Renal Insufficiency (Renal Failure)
10/2023
1Heart Failure
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Ketosis
12/2018
1Dyslipidemias (Dyslipidemia)
07/2015
1Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2013
1Injection Site Reaction
06/2013
1Rubella (German Measles)
12/2011
1Diphtheria
12/2011
1Measles
12/2011
1Mumps
12/2011
1Hepatitis
12/2011
1Tetanus
12/2011
1Insulinoma
12/2009
1Neoplasms (Cancer)
08/2009

Drug/Important Bio-Agent (IBA)

33Insulin (Novolin)FDA Link
01/2023 - 09/2002
28Glucose (Dextrose)FDA LinkGeneric
01/2024 - 09/2002
24AutoantibodiesIBA
01/2023 - 01/2007
20C-PeptideIBA
02/2024 - 01/2004
5AntigensIBA
01/2023 - 07/2011
4AntibodiesIBA
01/2016 - 05/2005
4Class 8 Receptor-Like Protein Tyrosine PhosphatasesIBA
06/2012 - 12/2009
3Abatacept (Orencia)FDA Link
01/2023 - 07/2011
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2019 - 07/2015
3Rituximab (Mabthera)FDA Link
02/2014 - 11/2009
2IncretinsIBA
01/2021 - 08/2013
2empagliflozinIBA
01/2020 - 12/2018
2Sodium-Glucose Transport ProteinsIBA
06/2019 - 01/2019
2Blood Glucose (Blood Sugar)IBA
06/2019 - 04/2014
2Monoclonal AntibodiesIBA
01/2019 - 02/2014
2Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2019 - 09/2018
2Metformin (Glucophage)FDA LinkGeneric
09/2015 - 09/2002
2Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
09/2011 - 07/2011
2PowdersIBA
11/2008 - 03/2007
2ExuberaFDA Link
11/2008 - 03/2007
2Ribosomal DNA (rDNA)IBA
11/2008 - 03/2007
1LipidsIBA
01/2024
1Cardiotonic Agents (Cardiac Stimulants)IBA
01/2024
1Mineralocorticoid Receptor AntagonistsIBA
01/2024
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2024
1SodiumIBA
01/2024
1AlbuminsIBA
10/2023
1finerenoneIBA
10/2023
1CreatinineIBA
10/2023
1Biomarkers (Surrogate Marker)IBA
10/2023
1Hormones (Hormone)IBA
09/2021
1Fc Receptors (Fc Receptor)IBA
01/2019
1teplizumabIBA
01/2019
1KetonesIBA
12/2018
1pegylated granulocyte colony-stimulating factorIBA
09/2018
1PeripherinsIBA
01/2016
1AutoantigensIBA
01/2016
1Recombinant ProteinsIBA
01/2016
1EpitopesIBA
01/2016
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2015
1RanolazineFDA Link
07/2015
1CarbohydratesIBA
07/2015
1Docosahexaenoic AcidsIBA
06/2015
1CytokinesIBA
06/2015
1Interleukin-1 (Interleukin 1)IBA
06/2013
1Immunomodulating AgentsIBA
06/2013
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
06/2013
1canakinumabFDA Link
06/2013
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2013
1ZincIBA
06/2012
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
12/2011
1VaccinesIBA
07/2011
1Aluminum Hydroxide (Algeldrate)FDA Link
07/2011
1aluminum sulfate (alum)IBA
07/2011
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2010
1Daclizumab (Zenapax)FDA Link
04/2010
1Insulin Glargine (Lantus)FDA Link
08/2009

Therapy/Procedure

21Therapeutics
02/2024 - 01/2004
5Glycemic Control
02/2024 - 01/2004
4Injections
01/2019 - 07/2005
3Islets of Langerhans Transplantation
02/2024 - 11/2021
2Immunotherapy
06/2013 - 07/2011
1Artificial Pancreas
09/2021
1Precision Medicine
10/2015
1Carbohydrate Loading Diet
07/2015
1Withholding Treatment
04/2014
1Hyperbaric Oxygenation
07/2012
1Aftercare (After-Treatment)
12/2011